MFRHX
Price
$64.14
Change
+$0.46 (+0.72%)
Updated
Oct 24 closing price
Net Assets
8.26B
VTSMX
Price
$162.41
Change
+$1.29 (+0.80%)
Updated
Oct 24 closing price
Net Assets
2.02T
Interact to see
Advertisement

MFRHX vs VTSMX

Header iconMFRHX vs VTSMX Comparison
Open Charts MFRHX vs VTSMXBanner chart's image
MFS Research R3
Price$64.14
Change+$0.46 (+0.72%)
VolumeN/A
Net Assets8.26B
Vanguard Total Stock Mkt Idx I
Price$162.41
Change+$1.29 (+0.80%)
VolumeN/A
Net Assets2.02T
MFRHX vs VTSMX Comparison Chart in %
View a ticker or compare two or three
VS
MFRHX vs. VTSMX commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFRHX is a StrongBuy and VTSMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 2.02T vs. MFRHX (8.26B). VTSMX pays higher dividends than MFRHX: VTSMX (1.04) vs MFRHX (0.41). MFRHX was incepted earlier than VTSMX: MFRHX (21 years) vs VTSMX (34 years). MFRHX (0.77) is less costly to investors than VTSMX (0.14). MFRHX is a more actively managed with annual turnover of: 20.00 vs. VTSMX (2.00). MFRHX has a lower initial minimum investment than VTSMX: MFRHX (0) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 16.88 vs. MFRHX (3.80). VTSMX return over 5 years is better than : 89.39 vs. MFRHX (32.56).
MFRHXVTSMXMFRHX / VTSMX
Total Expense Ratio0.770.14550%
Annual Report Gross Expense Ratio0.770.14550%
Fund Existence21 years34 years-
Gain YTD12.36915.25581%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.26B2.02T0%
Annual Yield % from dividends0.411.0440%
Returns for 1 year3.8016.8823%
Returns for 3 years31.8773.4343%
Returns for 5 years32.5689.3936%
Returns for 10 years78.73227.6235%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XFOR3.800.71
+22.98%
X4 Pharmaceuticals Inc
TRIB1.000.05
+5.67%
Trinity Biotech plc
CCOI42.960.24
+0.56%
Cogent Communications Holdings
MANH194.850.17
+0.09%
Manhattan Associates
EQV10.44N/A
N/A
EQV Ventures Acquisition Corp